Covovax
- December 19, 2021
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Covovax
Subject – Science and Tech
Context – WHO emergency nod for Serum Institute’s Covovax
Concept –
- The World Health Organisation said it had granted emergency approval to the India-manufactured coronavirus vaccine Covovax.
- The jab, produced by the Serum Institute of India under licence from the U.S – based Novavax, will now be distributed as part of global vaccine-sharing system Covax, giving a much-needed boost to ongoing efforts to vaccinate more people in lower income countries.
- Covovax requires two doses and is stable at 2 to 8 degrees Celsius refrigerated temperatures.